US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Lunai Bioworks Inc. - Common Stock (NQ:LNAI)

1.300 -0.080 (-5.80%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lunai Bioworks Inc. - Common Stock

News headline image
Parkinson’s Disease Platform Advanced via Exclusive Global Agreement with Tanaist, Inc. Adding Human Cellular Phenotyping for Lunai Bioworks (Nasdaq: LNAI)
Via Get News
Topics Artificial Intelligence
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery
Via Investor Brand Network
Topics Intellectual Property
InvestorNewsBreaks – Lunai Bioworks, Inc. (NASDAQ: LNAI) Targets Alleged Naked Short Sellers in Securities Fraud Lawsuit
Via Investor Brand Network
Topics Artificial Intelligence Fraud Intellectual Property
News headline image
Microcap March Madness: LNAI, FAGI, VSA, LNKS Sweet 16 Underdog Watch
Via AB Newswire
Topics Artificial Intelligence
News headline image
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
From BioMedWire
Via GlobeNewswire
News headline image
$400M to $1.2 Billion US Countermeasures Program Presents Huge Opportunity for New AI Platform to Meet Emerging Battlefield and Terrorism Threats: Lunai Bioworks (Nasdaq: LNAI)
Via Get News
Topics Artificial Intelligence Intellectual Property
News headline image
Full Alliance (OTCQB: FAGI) Aquaox Pure Solutions’ JusSpray™ Surges on Amazon Demand
Via AB Newswire
News headline image
Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds
Via ACCESS Newswire
News headline image
Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics
Via ACCESS Newswire
News headline image
Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement
Via ACCESS Newswire
News headline image
Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline
Via ACCESS Newswire